Detalles de la búsqueda
1.
Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis.
Lancet Oncol
; 25(4): 455-462, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38458207
2.
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group.
Lancet Oncol
; 24(2): e86-e95, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36725153
3.
Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma.
Qual Life Res
; 32(8): 2281-2292, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36935467
4.
Time to deterioration of symptoms or function using patient-reported outcomes in cancer trials.
Lancet Oncol
; 23(5): e229-e234, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489354
5.
Floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning Subscale among patients with advanced or metastatic breast cancer.
Cancer
; 128(4): 808-818, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34634139
6.
Timing is everything: The importance of patient-reported outcome assessment frequency when characterizing symptomatic adverse events.
Clin Trials
; 19(3): 267-273, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35575012
7.
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials.
Lancet Oncol
; 22(9): 1230-1239, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34310904
8.
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health.
Oncologist
; 26(10): e1786-e1799, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34196068
9.
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer.
Oncologist
; 26(5): 433-438, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33687763
10.
Does Knowledge of Treatment Assignment Affect Patient Report of Symptoms, Function, and Health Status? An Evaluation Using Multiple Myeloma Trials.
Value Health
; 24(6): 822-829, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34119080
11.
Patient-Reported Outcomes After Treatment Discontinuation: Commercial Clinical Trial Data From Four Cancer Types.
Value Health
; 24(9): 1302-1307, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452710
12.
Demystifying the estimand framework: a case study using patient-reported outcomes in oncology.
Lancet Oncol
; 21(10): e488-e494, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002444
13.
CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis.
Lancet Oncol
; 21(2): 250-260, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31859246
14.
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Lancet Oncol
; 21(2): e83-e96, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32007209
15.
Public-private partnerships in transplant drug development.
Am J Transplant
; 20(2): 377-381, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31553120
16.
Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs.
Oncologist
; 25(4): 348-354, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32297444
17.
Immune Response Evaluation and Treatment with Immune Checkpoint Inhibitors Beyond Clinical Progression: Response Assessments for Cancer Immunotherapy.
Curr Oncol Rep
; 22(11): 116, 2020 08 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32851542
18.
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease.
Qual Life Res
; 29(7): 1903-1911, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32100182
19.
Exploration of baseline patient-reported side effect bother from cancer therapy.
Clin Trials
; 17(3): 332-337, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32153216
20.
When less is more-reducing complexity in cancer trials.
Lancet Oncol
; 25(1): 10-12, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181803